Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. - Wikidata - wikimedia - TriplyDB

Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.

Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.

http://www.wikidata.org/entity/Q37105819

about

Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice Feasibility of intensity-modulated and image-guided radiotherapy for locally advanced esophageal cancer.A retrospective study of californium-252 neutron brachytherapy combined with EBRT versus 3D-CRT in the treatment of esophageal squamous cell cancer.A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma.Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer.18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer.Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis.Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome A retrospective study of external beam radiation, neutron brachytherapy, and concurrent chemotherapy for patients with localized advanced carcinoma of the esophagus Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer.A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)Pre-Chemoradiotherapy FDG PET/CT cannot Identify Residual Metabolically-Active Volumes within Individual Esophageal Tumors ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.Involved-field irradiation in definitive chemoradiotherapy for T4 squamous cell carcinoma of the esophagus Details of out-field regional recurrence after involved-field irradiation with concurrent chemotherapy for locally advanced esophageal squamous cell carcinoma Radiation field size and dose determine oncologic outcome in esophageal cancer.Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease.Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis.The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies.High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis.Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer.Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancer Enhanced radiosensitizing by sodium glycididazole in a recurrent esophageal carcinoma tumor model.Comparison of Acuros (AXB) and Anisotropic Analytical Algorithm (AAA) for dose calculation in treatment of oesophageal cancer: effects on modelling tumour control probability.Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern.Induction chemotherapy or chemoradiotherapy followed by radical esophagectomy for T4 esophageal cancer: results of a prospective cohort study.What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis.Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy.Expression profile of apoptosis-related genes potentially explains early recurrence after definitive chemoradiation in esophageal squamous cell carcinoma.Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer.

P2860

Q26753864-34CA4FA0-749A-447F-865D-9174EBA14CEC Q28073933-FC66226C-BF6C-4DA8-94B7-4312E4F39592 Q30413693-B81716E5-B5AB-43BB-8703-B542C3CB2ABC Q33427016-C3B6DB93-1BD6-420F-8476-EDF95DA1C83C Q33433296-8C35F60D-DBA4-4361-9B1C-458EFF780D98 Q33591706-1F7DF1C0-62DB-4DD2-8E75-591A025BB7E4 Q33597464-C363422F-AEAA-4941-84C3-078E9D75E49E Q33798433-6E33E526-7098-4271-B454-CA489F57C09A Q33882085-45918B03-33E9-4BB7-AE54-BCFD695F4707 Q33928837-C8A7D91E-BD63-4931-A381-6DF82AC00F2B Q34332847-CD953427-5650-46AB-95EB-3A0E949A0C15 Q34474357-E31EE3F9-F87F-4287-8832-92CBE7D4C021 Q34980099-7AE7274E-C43D-41CB-BE16-2A8CD48FFF97 Q34986535-CEE6EBE4-340E-40AA-9C98-55F7BA3CE6BB Q35728238-F77A0CC6-989B-4585-9C1A-473DCA6C0D16 Q35820777-2B21CDB0-58A9-4CB2-84F3-D47C6150FABF Q36055127-D04B4852-8C8F-44D5-900A-7AFC4C601E60 Q36299550-05F8012D-C5EB-4A06-B6C9-3B6F5F72F5C9 Q36413318-1860CBCB-F472-4CA6-B50F-EFDCAAD81F9A Q36807919-D8C30A71-07E4-4BB2-BC29-1C455F51FD9D Q36944123-1BE59C4E-A01D-4F6F-8C79-15339DC534D5 Q37340815-9F3DEC63-CAB9-4344-938A-B1E9956D97EA Q37617843-55D107C9-0BF8-4DA2-A3C1-419C95CC7A28 Q38151800-24DA9FD7-D934-4A10-9D14-B0315889F95B Q38161349-F2D53B80-F084-4FFA-A2A1-FD8DCC5A4B3F Q38226697-53C78488-5D16-4733-82EA-D33412A5E108 Q38559388-B3980BDA-DACE-47FD-A083-6C2B5FE71168 Q38715093-E0F9A36A-0F09-4C58-A321-7D199EC6C66A Q39115244-40E28D42-39FE-4E91-91C2-504CAFDE68C8 Q39251972-5E57E501-ABB2-4180-A60D-BDD22E298F0E Q39694301-02EB3FBB-932F-4FD5-B09A-379032DE63F0 Q41895460-241C547F-ADB0-45DB-BC45-C5C8F2DBF0BE Q43110953-D10A4E00-F66F-4769-9478-266A0B895A96 Q44708998-B2D509F8-D025-470C-8867-167261DEB3C9 Q46281811-BBC12981-61EF-46A1-BC92-140CF53BD267 Q47142547-970DBFD6-5C79-4934-A218-3339407DEB41 Q53000435-5E00DA40-D1B4-4688-8215-9840CC281D0F Q53158357-522935C2-B55D-434D-B829-D41FA0A708D0 Q54228548-B4E6F21D-0062-45C0-A43B-5945FF22D091 Q54652098-A05822CC-AD44-45B9-ABD1-9358B5394EF4

P2860

Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.

http://www.wikidata.org/entity/Q37105819

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Failure patterns in patients w ...... ith definitive chemoradiation.

@en

Failure patterns in patients w ...... ith definitive chemoradiation.

@nl

type

label

Failure patterns in patients w ...... ith definitive chemoradiation.

@en

Failure patterns in patients w ...... ith definitive chemoradiation.

@nl

prefLabel

Failure patterns in patients w ...... ith definitive chemoradiation.

@en

Failure patterns in patients w ...... ith definitive chemoradiation.

@nl

P1433

Q37105819-16D1541F-5EF3-447C-A6E9-7B996CBE881A

P1476

Q37105819-2075C9F3-53A9-481F-8126-AAA7C6FE4F2A

P2093

Q37105819-07B5215F-083D-4639-8D51-4F48130EB364

Q37105819-2018A928-DA82-4970-8D8D-C258951BBE74

Q37105819-2D4165C2-7C46-49B0-AA90-249FC9C37524

Q37105819-5DBF2D3F-F0F0-4ECE-9ED1-4F86EDC4F836

Q37105819-7BDF6DBC-F1CF-405B-9E3E-CE496D9DCD46

Q37105819-97856EC1-69B9-4795-AF9E-C6F440E6CCEA

Q37105819-A224E83C-716D-4CF3-BE96-6EC2673D28A4

Q37105819-B3F9ECDB-1687-4D5C-9E1B-BB364C99DB3A

Q37105819-E864FD15-D144-4D62-8270-40340AD8EAB4

P2860

Q37105819-0BDCB1D1-F73B-4C2E-8948-51F7748B3692

Q37105819-1D8841CD-3102-4FB6-B08C-B192445DB68B

Q37105819-251611D9-EB37-4491-8770-CFC9F48C771E

Q37105819-2C4153AD-1EF3-4DC6-920E-76A1D339F0E1

Q37105819-52F3F220-2476-4887-9EBF-8ABFCBF99C04

Q37105819-64208812-4B36-41E9-B84E-8D6F601D026A

Q37105819-6662D88C-1A88-4BEA-B6CC-91F3536D6EEB

Q37105819-6E499879-AEE2-4679-8BB9-762510FF5F09

Q37105819-71A7ACFE-5067-425B-8545-C3D7CDF69E1E

Q37105819-74398458-8D76-4BBB-A169-C9E470DD6A0E

P304

Q37105819-8DC85EBF-9CD4-42B2-85D4-C1DB3464BE57

P31

Q37105819-9EFE0FE5-4088-4062-AD75-B3E0D2189229

P356

Q37105819-ADB6D962-BA9B-4717-AACB-90A02A67F4CD

P407

Q37105819-296A7A1B-01E2-4008-B8F7-19636F0A46E3

P433

Q37105819-2561F649-8A7E-48E4-91DC-34EB87A1863B

P478

Q37105819-7C4D1A62-CD0C-4237-A0C6-D1CE86FA6CBF

P50

Q37105819-DA1DBF62-4959-4FB8-BBC6-AD70EB81E6EF

P577

Q37105819-4CE4E49D-5999-41D2-9A72-8450F3E04F15

P5875

Q37105819-02776021-03DA-4D37-9E9E-D7F34A97228B

P698

Q37105819-B6DA3DA8-B9AE-449C-AA54-1DBD7CC92117

P921

Q37105819-0111B0B8-9889-4286-90B8-39DF9A2CFBF5

Q37105819-44CBD4FA-2CDD-4B8B-9EF6-DCA8C8683EA6

P932

Q37105819-D12E984F-3622-4FEA-B024-6380DFBBCDA4

P356

P1433

P1476

Failure patterns in patients w ...... ith definitive chemoradiation.

@en

P2093

Akihiro Suzuki

http://www.w3.org/2001/XMLSchema#string

Arya Amini

http://www.w3.org/2001/XMLSchema#string

Jaffer A Ajani

http://www.w3.org/2001/XMLSchema#string

James Welsh

http://www.w3.org/2001/XMLSchema#string

Lianchun Xiao

http://www.w3.org/2001/XMLSchema#string

Stephen H Settle

http://www.w3.org/2001/XMLSchema#string

Wayne Hofstetter

http://www.w3.org/2001/XMLSchema#string

Yuki Hayashi

http://www.w3.org/2001/XMLSchema#string

Zhongxing Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Intensity modulated proton therapy treatment planning using single-field optimization: the impact of monitor unit constraints on plan quality.

Principles of chemoradiation: theoretical and practical considerations.

Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.

Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer.

Treatment of locoregional esophageal cancer.

Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.

Challenges in the clinical application of advanced technologies to reduce radiation-associated normal tissue injury.

Chemoradiation in the management of esophageal cancer.

P304

2632-2640

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.26586

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224918033

http://www.w3.org/2001/XMLSchema#string

P698

22565611

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3747650

http://www.w3.org/2001/XMLSchema#string